SCHEMBL5058736

SCHEMBL5058736

CCOC(=O)CCOCC(COCCC(=O)OCC)(COCCC(=O)OCC)NC(=O)CCNC(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
HTT P42858 1/20 0.46
MAPT P10636 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
PRSS1 P07477 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5050709 0.88 HTT (0.57) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL5128921 0.88 LMNA (0.46) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL30290791 0.83 LMNA (0.49) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL24572574 0.82 LMNA (0.56) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3295121 0.82 HTT (0.62) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL26689424 0.81 LMNA (0.60) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL5050635 0.81 LMNA (0.51) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL24572629 0.81 LMNA (0.63) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL20224802 0.80 SMN1; SMN2 (0.47) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL21415413 0.80 BCHE (0.40) LMNASMN1; SMN2MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7862807-B2 Dendrimers as molecular translocators UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2011-01-04 US disclosed
US-20080221020-A1 Dendrimers as Molecular Translocators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-09-11 US disclosed
US-20060216265-A1 Dendrimers as molecular translocators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060216265-A1 Dendrimers as molecular translocators SLC29A1, SLC29A2, TSPO LMNA 2444/4885SMN1; SMN2 3103/4885MEN1 3202/4885
US-20080221020-A1 Dendrimers as Molecular Translocators SLC29A1, SLC29A2, TSPO LMNA 2444/4885SMN1; SMN2 3103/4885MEN1 3202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.